Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside

Vijaya L. Damaraju, Frank Visser, Jing Zhang, Delores Mowles, Amy M.L. Ng, James D. Young, Hiremagalur N. Jayaram, Carol E. Cass

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Benzamide riboside (BR) and tiazofurin (TR) are converted to analogs of NAD that inhibit IMP dehydrogenase (IMPDH), resulting in cellular depletion of GTP and dGTP and inhibition of proliferation. The current work was undertaken to identify the human nucleoside transporters involved in cellular uptake of BR and TR and to evaluate their role in cytotoxicity. Transportability was examined in Xenopus laevis oocytes and Saccharomyces cerevisiae that produced individual recombinant human concentrative nucleoside transporter (CNT) and equilibrative nucleoside transporter (ENT) types (hENT1, hENT2, hCNT1, hCNT2, or hCNT3). TR was a better permeant than BR with a rank order of transportability in oocytes of hCNT3 ≫ hENT1 > hENT2 > hCNT2 ≫ hCNT1. The concentration dependence of inhibition of [3H]uridine transport in S. cerevisiae by TR exhibited lower Ki values than BR: hCNT3 (5.4 versus 226 μM), hENT2 (16 versus 271 μM), hENT1 (57 versus 168 μM), and hCNT1 (221 versus 220 μM). In cytotoxicity experiments, BR was more cytotoxic than TR to cells that were either nucleoside transport-defective or -competent, and transport-competent cells were more sensitive to both drugs. Exposure to nitrobenzylmercaptopurine ribonucleoside conferred resistance to BR and TR cytotoxicity to hENT1-containing CEM cells, thereby demonstrating the importance of transport capacity for manifestation of cytoxicity. A breast cancer cell line with mutant p53 exhibited 9-fold higher sensitivity to BR than the otherwise similar cell line with wild-type p53, suggesting that cells with mutant p53 may be potential targets for IMPDH inhibitors. Further studies are warranted to determine whether this finding can be generalized to other cell types.

Original languageEnglish (US)
Pages (from-to)273-279
Number of pages7
JournalMolecular pharmacology
Volume67
Issue number1
DOIs
StatePublished - Jan 2005

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint Dive into the research topics of 'Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside'. Together they form a unique fingerprint.

  • Cite this

    Damaraju, V. L., Visser, F., Zhang, J., Mowles, D., Ng, A. M. L., Young, J. D., Jayaram, H. N., & Cass, C. E. (2005). Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside. Molecular pharmacology, 67(1), 273-279. https://doi.org/10.1124/mol.104.004408